Stay updated on Dabrafenib Trametinib Pre Post-Surgery Melanoma Clinical Trial
Sign up to get notified when there's something new on the Dabrafenib Trametinib Pre Post-Surgery Melanoma Clinical Trial page.

Latest updates to the Dabrafenib Trametinib Pre Post-Surgery Melanoma Clinical Trial page
- Check7 days agoChange DetectedVersion 34 (2026-02-11) adds the Study Status to the history; the 2026-02-13 update confirms its presence, and a 2025-08-06 deletion removes an earlier entry.SummaryDifference0.3%

- Check14 days agoChange DetectedRevision v3.4.2 was added to the history; the funding lapse notice and an older revision note were removed.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a government funding lapse notice and updated the site revision to v3.4.1; removed the previous revision reference v3.4.0.SummaryDifference0.5%

- Check28 days agoChange DetectedGlossary toggle and color-coding explanations for changes were added, and the revision header now shows v3.4.0 (replacing v3.3.4).SummaryDifference0.7%

- Check42 days agoChange DetectedThe history shows a new revision entry (v3.3.4) added and an older entry (v3.3.3) removed. This update affects only the revision log and does not alter study data, eligibility criteria, or results.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.3.3 was added to the page history; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.1%

Stay in the know with updates to Dabrafenib Trametinib Pre Post-Surgery Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dabrafenib Trametinib Pre Post-Surgery Melanoma Clinical Trial page.